Pharmaceutical Industry Blog

India has emerged as a global hub for pharmaceutical manufacturing, particularly in the sterile injectables sector. As a WHO-GMP certified pharmaceutical CMO/CDMO specializing in sterile injectables, including liquid ampoules, vials, lyophilized products, and emulsions, I have witnessed firsthand the growth and innovation in this field. This article explores the top small parenteral manufacturing companies in India, highlighting their capabilities, compliance standards, and c

Farbe Firma Pvt Ltd stands as a beacon of excellence in the pharmaceutical manufacturing sector. As a WHO-GMP certified Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO), we specialize in sterile injectables. Our portfolio includes liquid ampoules, vials, lyophilized products, and emulsions. We deliver high-quality, compliant, and reliable manufacturing solutions tailored to meet the stringent demands of healthcare provid

Last Updated:  February 8, 2026 TL;DR Summary Farbe Firma Pvt. Ltd. is announced an HR Manager vacancy in pharma  at our Ankleshwar facility. We seek an experienced professional to oversee talent management, compliance, and organizational growth. This role offers a strategic opportunity to lead HR operations in a top-tier pharmaceutical environment. Key Takeaways Primary Role:  Strategic HR management and talent acquisition. Location:  Ankleshwar, Gujarat (Pharma Hub). Indus

Last Updated: January 29, 2026 TL; DR (Summary) The Injectable Formulation CDMO  (Contract Development and Manufacturing Organization) sector provides essential end-to-end services for sterile drug products. By 2026, this market has become a cornerstone of the pharmaceutical supply chain, offering specialized expertise in aseptic filling , lyophilization, and complex generic development. Key Takeaways Technical Complexity:  Requires high-tier aseptic fill-finish  capabilities

Last Updated: January 29, 2026 TL; DR (Summary) The Bacteriostatic Water for Injection Market  is a critical segment of the pharmaceutical industry, valued at approximately $1.32 billion in 2025. It is projected to grow significantly as demand for multi-dose injectable medications rises. This sterile solution, containing 0.9% benzyl alcohol, ensures high chemical stability and patient safety during drug reconstitution. Key Takeaways Antimicrobial Efficiency:  Contains 0.9% be

In the rapidly evolving pharmaceutical industry, the demand for high-quality sterile injectable products continues to grow. Healthcare providers worldwide rely on safe, effective, and innovative formulations to treat patients across various medical conditions. As a WHO-GMP certified pharmaceutical CMO/CDMO, we specialize in manufacturing sterile injectables, including liquid ampoules, vials, lyophilized products, and emulsions. Our commitment to quality, compliance, and relia